Physician

Adedapo Adeyinka Iluyomade, M.D.

According to 2025 Medicare claims, Adedapo Iluyomade, M.D. (NPI: 1235576257) practices cardiology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP PHYSICIANS LLC (NPI: 1891893343; TIN: 205155995) and primary practice location at 33173-5458. Iluyomade is affiliated with the Baptist Health Quality Network LLC (ACO ID: A5013), participating under the MSSP model.

Iluyomade's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 714 traditional Medicare patients, billed 1,234 HCPCS/CPT codes, and received $61,394 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 2,686 prescription claims across 333 beneficiaries totaling $760,679 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 12 claims. Open Payments data shows 28 records totaling $23,489. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,609 to $61,394. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,055 to $760,679. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	119	185	$16,609
2021	323	446	$37,622
2022	351	616	$51,959
2023	511	801	$55,045
2024	714	1,234	$61,394

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	15	$1,055
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	60	$3,262
2019	N/R	92	$8,108
2020	45	186	$12,515
2021	134	657	$52,912
2022	195	826	$114,453
2023	236	1,467	$310,514
2024	333	2,686	$760,679

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$2,761
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	155	155	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	126	217	$95
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	56	102	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	72	104	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	303	400	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	176	9,031	$170,886
Xarelto	Rivaroxaban	66	4,200	$72,771
Entresto	Sacubitril/Valsartan	52	3,360	$60,440
Ozempic	Semaglutide	41	1,856	$55,930
Farxiga	Dapagliflozin Propanediol	39	2,965	$53,894

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$4,098	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$19,391	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adedapo Adeyinka Iluyomade, M.D.?

Tedicare shows public-source Medicare data for Adedapo Adeyinka Iluyomade, M.D. (NPI 1235576257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adedapo Adeyinka Iluyomade, M.D. have ACO affiliation data?

Adedapo Adeyinka Iluyomade, M.D. is shown with ACO affiliation data for Baptist Health Quality Network LLC (MSSP, ACO ID A5013).

What billing organization is linked to Adedapo Adeyinka Iluyomade, M.D.?

Adedapo Adeyinka Iluyomade, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP PHYSICIANS LLC (billing NPI 1891893343) in the available physician profile data.

Does Adedapo Adeyinka Iluyomade, M.D. have Open Payments data?

Adedapo Adeyinka Iluyomade, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.